Candriam SCA’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-175,008
| Closed | -$1.46M | – | 713 |
|
|
2023
Q3 | $1.46M | Hold |
175,008
| – | – | 0.01% | 494 |
|
|
2023
Q2 | $1.62M | Sell |
175,008
-12,791
| -7% | -$118K | 0.01% | 537 |
|
|
2023
Q1 | $2.38M | Buy |
187,799
+28,814
| +18% | +$364K | 0.02% | 536 |
|
|
2022
Q4 | $2.7M | Buy |
158,985
+110,225
| +226% | +$1.87M | 0.02% | 518 |
|
|
2022
Q3 | $1.11M | Buy |
+48,760
| New | +$1.11M | 0.01% | 687 |
|
|
2021
Q3 | – | Sell |
-122,029
| Closed | -$10.2M | – | 890 |
|
|
2021
Q2 | $10.2M | Buy |
122,029
+13,137
| +12% | +$1.09M | 0.07% | 282 |
|
|
2021
Q1 | $9.24M | Hold |
108,892
| – | – | 0.08% | 265 |
|
|
2020
Q4 | $9.61M | Sell |
108,892
-21,395
| -16% | -$1.89M | 0.08% | 271 |
|
|
2020
Q3 | $9.62M | Sell |
130,287
-6,081
| -4% | -$449K | 0.09% | 243 |
|
|
2020
Q2 | $9.96M | Buy |
136,368
+136,360
| +1,704,500% | +$9.96M | 0.11% | 216 |
|
|
2020
Q1 | $0 | Buy |
+8
| New | – | ﹤0.01% | 794 |
|